• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2021 State of Survivorship Survey Results Briefing
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

NCCS Starburst Thumbnail

Association for Molecular Pathology v. Myriad Genetics, Inc.

June 14, 2013/in Cancer News NCCS News /by actualize

The Supreme Court ruled unanimously on June 13, 2013, that isolated human genes may not be patented.   The opinion, written by Justice Clarence Thomas for the unanimous Court, stated: “Had Myriad created an innovative method of manipulating genes while searching for the BRCA1 and BRCA2 genes, it could possibly have sought a method patent.  But the processes used by Myriad to isolate DNA were well understood by geneticists at the time.” Cancer patient advocates, oncologists, and cancer researchers had closely monitored the case because of the implications of the ruling for the cost of the BRCA1 and BRCA2 gene tests as well as the potential impact on research and development of additional gene tests.

The plaintiffs in the case — Association for Molecular Pathology v. Myriad Genetics, Inc. – claimed that the ruling would have an immediate impact on people’s health by reducing the cost of the BRCA tests.   Robert Cook-Deegan, a research professor at Duke University’s Institute for Genome Sciences and Policy, was quoted in the New York Times, “I think that there might be some blustering or saber rattling, but I would be really surprised if they sue anybody for patent infringement for a diagnostic test.”

Others described the ruling as a partial victory for Myriad because the court held that complementary DNA, or cDNA, could be patented.  Peter Meldrum, Myriad President and CEO, was quoted in the Washington Post: “We believe the Court appropriately upheld our claims on cDNA, and underscored the patent eligibility of our method claims, ensuring strong intellectual property protection for our BRCAnalysis test moving forward.”

 

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2012/12/NCCS_Starburst_Thumbnail.jpg 125 125 actualize http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2013-06-14 09:53:562013-06-14 09:53:56Association for Molecular Pathology v. Myriad Genetics, Inc.

Latest News

Kara Kenan Advocate Spotlight

Kara Kenan: Helping Others is the Greatest Reward of Advocacy

August 3, 2022
“Nobody wins afraid of losing” rings true for Kara Kenan, a breast cancer survivor. It’s her favorite line from Chris Stapleton’s…
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Kara-Kenan.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-08-03 12:20:482022-08-03 12:20:48Kara Kenan: Helping Others is the Greatest Reward of Advocacy
Care and Career Support From Health Systems to Employers Webinar

Webinar – Care and Career Support: From Health Systems to Employers

August 3, 2022
NCCS hosted a webinar about the unique demands of caregiving in cancer and strategies that employers and health systems might engage…
Read more
https://canceradvocacy.org/wp-content/uploads/Care-and-Career-Support-webinar-post-1200px.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-08-03 10:24:462022-08-03 10:24:46Webinar – Care and Career Support: From Health Systems to Employers
Bethany Ross

Bethany Ross: Advocating for Quality Cancer Care Through Storytelling

July 7, 2022
Advocate Spotlight July 2022 - Bethany Ross Bethany Ross is a four-year neuroendocrine cancer survivor, or “cancer badass,”…
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Bethany-Ross-web.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-07-07 16:53:522022-07-07 16:53:52Bethany Ross: Advocating for Quality Cancer Care Through Storytelling

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2021 State of Survivorship Survey Results Briefing
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Journey Forward™ Program Is Finalist in the Crowds Care 4 Cancer Challeng... journeyforward Dome Thumbnail starburst NCCS endorses the Carolyn Pryce Conquer Childhood Cancer Reauthorization Ac...
Scroll to top
Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute